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Abstract
The rate at which agile software development practices are being adopted is growing rapidly. Agile
software development practices and methodologies appear to offer the silver bullet which can solve
the problems associated with following plan driven software development lifecycles. Agile software
development practices offer the possibility of achieving lower development costs, increased efficiency
and improved software quality. However, there is currently a low rate of publicly available information
that suggests there is widespread adoption of agile practices within the medical device software domain. This is largely due to the fact that software developed for medical devices includes challenges
not faced when developing non safety critical software. As a result of these challenges, medical device
software is typically developed using plan driven software development lifecycles. However, such lifecycles are quite rigid and cannot accommodate changes easily. Previous research has revealed that
medical device software development projects can benefit from adopting agile practices whilst still
maintaining the discipline associated with following plan driven development lifecycles. This paper
outlines the challenges faced by developers when developing medical device software and how shortcomings in both agile and plan driven approaches can be resolved by following a mixed method approach to medical device software development.
Keywords
Medical Device, Agile, Plan Driven, SDLC, XP, Scrum, V-Model, TDD, FDA, MDD,
2007/47/EC, Software Process Improvement

1 Introduction
Software developers are under increasing pressure to develop software faster that not only meets
a customer’s requirements, but exceeds them [1]. Initially, iterative software development appeared to
offer a solution by aiding faster development of systems. Iterative techniques evolved and a subset
known as agile appeared [2]. Larmin and Basili [3] identified Dynamic Systems Development Model
(DSDM) as being the first agile methodology. Each of the agile methodologies consists of a number of
agile practices. These practices are procedures defined as being highly effective and efficient [4] such
as sprint planning, an open office space, daily meetings and from Scrum, product backlogs [5]. The
use of agile methodologies such as XP and Scrum, in traditional software development projects are
becoming increasingly popular [6].
In some case studies, agile practices have been used in the safety critical field. For instance, in
Motorola, a select number of XP practices were used during the development of safety critical systems [7]. In these cases, the use of XP practices was reported to have had a 53% improvement in
average quality compared to the plan-driven software development projects. A key challenge in these
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XP projects was to define how the changes affected the overall end date of the projects. Additionally,
Drobka et al.[7] discusses the issue of documentation production. In the case of Grenning [8], the
source code was not sufficiently documented for the whole system, and this resulted in the need for a
high-level architecture document which provided class diagrams, scenarios and a process view of the
system for developers. Furthermore, acceptance tests were not adequate to verify the traceability from
end product to customer requirements. Therefore, additional verification review meetings were used to
cover this gap in the verification process [7]. Grenning [8] describes how XP practices such as the
planning games, small releases, simple design, test first development; refactoring, pair programming,
collective ownership, continuous integration and 40 hour week are used in a large company developing safety critical systems. As a result of this analysis, he suggests that some XP practices, such as
simple designs integrated with test first development and refactoring work quite well in the safety critical area. In that case, the managers were reported to be happy with the results of the use of XP practices. This was mainly due to the XP team’s ability to readily produce working software instead of a
high amount of documentation [8]. One of the biggest challenges revealed from this case was that
resistance was caused mainly due to the decreased amount documentation. This documentation was
needed, for example, to define product requirements, sustain technical reviews, support maintenance
and describe interfaces. Based on the experiences of the XP projects it was still understood that the
documentation was needed for maintenance and review purposes [8].
In spite of these experiences of adopting agile practices in the safety critical domain, there is still little evidence of agile practices being widely embraced when developing medical device software [9].
The reason for this is still unclear, but one potential reason is that safety critical systems must also
meet the appropriate regulatory requirements [10]. As part of the Food and Drug Administration (FDA)
regulations most items require formal approval and this is cited as being a reason why many medical
device software developers follow a sequential software development model such as the Waterfall or
V-Model [11]. Of the limited information available, medical device software projects can benefit from
incorporating agile practices, but no single agile methodology can be followed when developing medical device software [12].
It is generally perceived that international medical device regulatory requirements recommend that
software developed either as a component of a medical device or as a medical device should be developed in accordance with a plan driven software development lifecycle such as the Waterfall Model
or the V-Model. However, the regulatory requirements and development standards do not enforce the
usage of any particular software development lifecycle. Whilst no specific software development lifecycle is mandated by the regulations or standards medical device software developers typically develop software in accordance with the V-Model [13]. Following the V-Model produces the necessary
deliverables required in order to achieve regulatory approval. The objective of this research is to develop a Software Development Life Cycle (SDLC) that accrues the benefits of utilising agile practices
whilst still producing the necessary deliverables provided by following plan driven software development lifecycles. This paper will serve as the foundation for this research. The remainder of this paper
will be structured as follows.
In section 2, the latest regulatory requirements which medical device software organisations must
adhere to are outlined. In section 3, information is provided as to how regulatory bodies do not require
the usage of a specific software development lifecycle and that regulatory bodies are only concerned
with the specific requirements such as traceability rather than being concerned with how these requirements are fulfilled. In section 4, a mixed method software development lifecycle is proposed that
incorporates agile practices with a plan driven lifecycle and finally in section 5, the conclusions and
plans for future work are presented.

2 International Regulations
Medical device software developers must adhere to the regulatory requirements of the region in
which a medical device is being marketed for use. Medical devices being marketed for use within the
United States (US) must conform to the FDA requirements and medical devices being marketed for
use within the European Union (EU) must conform to the Medical Device Directive (MDD) and its latest amendment.
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2.1

European Medical Device Directive
st

On March 21 2010 the latest amendment to the MDD 2007/47/EC came into effect [14]. As stated,
conformance to the latest amendment to the MDD is mandatory for a medical device to be marketed
for use in the EU. Competent Authorities and notified bodies within each EU member state are responsible for certifying medical device conformance with the MDD. Once a device is certified within an
EU member state the device can be marketed into all of the member states.
The latest amendment to the MDD introduced a number of changes; the most significant with regards to software development is that standalone software can now be classified as an active medical
device. Prior to this amendment software was considered a component of a hardware medical device.
With the release of this amendment software can now potentially be the only component of a medical
device and therefore subject to full regulatory scrutiny. With this change a greater emphasis falls onto
the international standards which are followed during the development of medical device software. IEC
62304:2006 [15] is a harmonised standard as part of the MDD [16]. Medical device software developers are recommended to follow IEC 62304 and its aligned standards to receive guidance. However,
these aligned standards can be difficult to follow and this is particularly relevant when a medical device only consists of software.

2.2

FDA Regulations

Within the US the FDA is responsible for ensuring medical devices certified for use are safe and reliable. The FDA provides guidance documents which medical device software developers are recommended to follow in order to achieve regulatory conformance. These documents include:
• General Principles of Software Validation (GPSV) [17];
• Medical Device Data Systems Rule [18];
• Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices
[19];
• Draft Guidance for Industry and Food and Drug Administration - Mobile Device Applications [20];
• Guidance for Industry, FDA Reviewers and Compliance on Off-The-Shelf Software use in Medical
Devices [21].
All medical device manufacturers wishing to achieve FDA approval must conform to FDA 21 CFR
Part 820 Quality System Regulations (QSR) [22]. FDA 21 CFR Part 820 requires medical device
manufacturers to provide sufficient evidence that a Quality Management System (QMS) was employed when developing a medical device. To accompany, this all medical device manufacturers
wishing to achieve FDA approval must follow FDA General Controls [23]. These controls include provisions that relate to device registration, branding and banned devices.

3 Agile Practices in the Development of Medical Device Software
When exploring possible frameworks for developing medical device software, we discovered that
developers in this domain often select a plan driven lifecycle such as the V-Model [24], rather than
considering following agile practices with iterative or incremental development lifecycle. This may be
due to the fact that the agile manifesto places greater emphasis on people rather than processes and
also considers documentation as being a secondary output from a software development project [25].
In practice, formal communication, such as source code, test cases, and essential amount of documentation is also used in the agile software development, but not in the same way or to the same extent as
in the plan-driven software development process [26]. Additionally, some of the agile principles suggest that business people and developers must work together daily and project information should be
shared through informal, face-to-face conversation rather than through documentation [27].
However, regulatory bodies in both the US and Europe require medical device manufacturers to
provide documentation which provides information on areas such as risk and hazard management and
traceability between the requirements stage and the development stages of a software development
project [28, 29]. While this is the case, both the FDA guidelines and the MDD do not mandate the use
of a specific life cycle model. The FDA states:
“(the FDA) does not recommend the use of any specific software life cycle model. Software developers
should establish a software life cycle model that is appropriate for their product and organization”
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To accompany this the FDA also states that the selected life cycle model “should cover the software
from its birth to its retirement”, and also that the lifecycle model should support validation and verification [17]. As discussed medical device software development organisations are recommended to follow IEC 62304 when developing medical device software. IEC 62034 states:
“The (IEC 62304) standard does not require a particular software development life cycle model”
To accompany this IEC 62304 also states;
“Whichever life cycle is chosen it is necessary to maintain the logical dependencies between
process outputs”
IEC 62304 does not mandate the use of a specific lifecycle and is more concerned with the regulatory
requirements such as traceability and not with how these requirements are fulfilled. Both the FDA
GPSV guidance document and the IEC 62034 standard discuss the use of different life cycle models
including the waterfall, incremental and evolutionary models. The FDA GPSV states:
“Most software development models will be iterative. This is likely to result in several versions
of both the software requirement specification and the software design specification”
Currently, the Association of Advancement of Medical Instrumentation (AAMI) (the publishers of IEC
62304) is in the process of completing a technical information report which will provide recommendations as to how medical device software development organisations can comply with international and
FDA regulations by using agile practices [30]. This document will provide a complete mapping between the 12 agile principles [31] and each of the development stages of IEC 62304. All of this information signals that regulatory bodies acknowledge that following a plan driven software development
lifecycle is not always feasible and that agile practices can be used in compliance with IEC 62304
without jeopardising the process of achieving regulatory approval.
A number of case studies have been performed in organisations that are actively utilising agile
practices in the development of medical device software [12, 32-34]. A common trend emerged out of
these case studies that medical device software development organisations recognised it was not
possible to fully replace the existing lifecycle with a single agile methodology, but rather they integrated agile practices with the plan driven development lifecycle. Heeager and Nielsen [32]
recommend wrapping the traditional lifecycle in a Scrum approach [35]. Likewise, Robres [36]
explored the suitability of using Scrum to develop medical device software when attempting to achieve
regulatory conformance. In these case, the benefits to be achieved when using agile practices to
develop medical device software reflect those achieved when using agile practices in any software
development project, they include, reduced development time, reduced costs and increased productivity [37].

4 Proposed Mixed Method SDLC
It is well established that tailoring a SDLC should be done in order to achieve maximum impact [6].
As part of this research we are focusing on integrating agile practices with a plan driven lifecycle. The
aim of tailoring a plan driven lifecycle with agile practices is to develop a SDLC which produces the
necessary output required for regulatory approval whilst also reaping the benefits associated with utilising agile practices. To perform this tailoring effectively a foundation of a plan driven SDLC was
needed. This was required as none of the agile methodologies provide comprehensive coverage of all
the necessary development stages required when developing safety critical software [38]. However,
Turk [38] does recommended that a safety critical software development project can benefit from
combining agile techniques with formal plan driven techniques. The V-Model was chosen as medical
device software developers are familiar with the V-Model and it produces the necessary outputs required to achieve regulatory approval and provides guidance for all of the stages of medical device
software development. Secondly, research was conducted into which agile practices could be integrated into this plan driven SDLC. The agile practices initially selected were identified through the use
of a literature review. The agile practices and SDLC selected must conform to the regulatory requirements whilst still achieving the benefits of tailoring.
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4.1

Research Methodology

As part of on-going research into the area of utilising agile practices when developing medical device software a literature review was conducted. This literature was conducted in accordance with
Randolph [39]. The literature review began broadly by examining the main software development lifecycles being followed in all software development domains. The literature review then focused on
software development in safety critical industries and then concentrated on software development in
the medical device domain. Once this part of the literature review was completed, agile methodologies
were examined. After this examination was completed the focus moved onto the utilisation of agile
practices when developing safety critical software. When conducting the final phase of the literature
review a number of seminal papers in the area of using agile practices when developing medical device software were identified [11, 12, 32-34, 40, 41]. In each case study performed, the organisations
were initially developing medical device software in accordance with plan driven software development
lifecycles. Each of the organisations identified the need to embrace agile software development practices. Consequently upon completion of the implementation of the agile practices each organisation
found a noticeable improvement in software quality and increased functionality along with reduced
development costs. Table 1 presents summarised findings of the literature review and of the seminal
case studies identified. Table 1 shows the case studies identified and which agile practices each of
these case studies utilised

4.2

Integrating Agile Practices with a Plan Driven SDLC

As stated when developing a mixed method Software Development Life Cycle a foundation is required. This foundation came in the form of a V-Model for certification proposed by Ge et al. [10]. This
V-Model differs from the typical V-Model as it includes development stages for “Hazard and Risk Analysis” and “Regulatory Certification”. These stages are critical which software developed for use in
medical devices must complete.
Once the foundation was chosen a method was required to establish which agile practices would
be merged with the V-Model. The findings of the literature review were used to establish which agile
practices have so far been successfully implemented when developing medical device software. In
table 1, a summary of the agile practices suitable for use when developing medical device software
are outlined.

Table 1. Case Studies and Agile Practices utilised

Each of the agile practices used in these case studies were then incorporated into the relevant
stage of the V-Model. Figure 1 shows the tailored V-Model. This combines the V-Model proposed by
Ge et al. and the appropriate agile practices as identified through the literature review.
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Figure 1 V-Model Incorporating Agile Practices

As part of the literature review, agile practices were identified through the key case studies performed. However, none of the key case studies provide information as to which stage of development
the agile practices were incorporated. Despite this, we have performed a mapping which matched the
agile practices to the appropriate stage of development, as a number of the practices are more suited
to specific development stages e.g. Pair Programming = Module Construction and Testing.

5 Conclusions and Future Work
In conclusion, research into instances of agile adoption when developing medical device software
has shown that these projects can benefit from integrating agile practices. Medical device software
development organisations are bound by regulatory controls. These regulatory controls prevent medical device organisations from wholly embracing a single agile methodology when developing medical
device software. The findings of the literature review revealed that there is no SDLC currently available which medical device software developers can follow which produces the necessary deliverables
required to achieve regulatory conformance whilst reaping the benefits of utilising agile practices. Research has been conducted in isolation within organisations such as Medtronic and Cochlear, but no
evidence exists that suggest the models used in these organisations can be followed with the same
level of success in other medical device organisations. A common trend also appeared within each of
these case studies. This trend was that no single agile methodology was appropriate for use when
developing medical device software and that medical device software development projects benefit
from a mixed method approach combining agile practices with a plan driven software development
lifecycle. To this end it becomes apparent that medical device software development organisations
would greatly benefit from the development of a SDLC that meets both the organisational needs provided from following a plan driven lifecycle and developmental needs from following agile practices.
Research conducted as part of this paper will be used as the foundation for the development of a
tailored V-Model which integrates agile practices which are beneficial to the development of medical
device software and facilitate the achievement of regulatory compliance. To establish which agile
practices should be included into the tailored V-Model, every agile practices within each of the agile
methodologies i.e. Scrum, XP, Test Driven Development, Crystal etc. will be examined to determine
suitability for use when developing medical device software. Once suitability is determined the appropriate practices will be integrated into the tailored V-Model.
This tailored V-Model will be developed in collaboration with medical device software organisations in Ireland. Once the tailored V-Model is completed it will be thoroughly tested by industry. Once
this model has been finalised the objective is to have a medical device software development project
fully developed in accordance with the finalised tailored V-Model.
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